Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Initial review, 17410 [2013-06436]

Download as PDF 17410 Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices Proposed Project Prevention Research Centers Program National Evaluation Reporting System— Revision—Division of Population Health, National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Prevention Research Centers (PRC) Program was established by Congress through the Health Promotion and Disease Prevention Amendments of 1984. PRCs conduct outcomes-oriented health promotion and disease prevention research on a broad range of topics using a multi-disciplinary and community-based approach. CDC manages the PRC Program and currently provides funding to PRC grantees that are housed within schools of public health, medicine or osteopathy. Awards are made for five years and may be renewed through a competitive application process. CDC is currently approved to collect performance information from PRCs through a web-based survey and telephone interview (OMB #0920–0650, exp. 6/30/2013). The web-based survey is designed to collect information on the PRCs’ collaborations with health departments; formal training programs and other training activities; and other funded prevention research projects conducted separately from their core research. A structured telephone interview with a key PRC informant obtains information on systems and environmental changes in which PRCs are involved. The content of the information collection is guided by a set of performance indicators developed (2002) and later revised (2009) in collaboration with the PRCs. CDC requests OMB approval to continue conducting the annual webbased survey and the annual interview. Changes to be implemented include (1) changing the platform of the web-based survey, (2) reducing the number of questions asked on each instrument, and (3) revising some questions for clarity or to reflect the current needs and priorities of the program. The proposed changes will result in a net decrease in burden to respondents. OMB approval is requested for a three-year period with a start date of June 1, 2013. There are no costs to respondents other than their time. The total estimated burden hours are 204. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondent Form name PRC Program ......................................... Survey ................................................... Telephone Interview .............................. Ron A. Otten, Director, Office of Scientific Integrity (OSI), Office of the Associate Director for Science (OADS), Office of the Director. [FR Doc. 2013–06493 Filed 3–20–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention emcdonald on DSK67QTVN1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Initial review The meeting announced below concerns Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events, Funding Opportunity Announcement (FOA) CK11– 0010301SUPP13, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: 15:09 Mar 20, 2013 Jkt 229001 37 37 Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events, FOA CK11–0010301SUPP13’’. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–06436 Filed 3–20–13; 8:45 am] BILLING CODE 4163–18–P Time and Date: 1:00 p.m.–4:00 p.m., May 8, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, VerDate Mar<14>2013 PO 00000 Frm 00062 Fmt 4703 Number of responses per respondent Number of respondents Sfmt 4703 Average burden per response (in hours) 1 1 5 0.5 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention—Health Disparities Subcommittee (HDS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee: Time and Date: 9:00 a.m.–4:45 p.m. EDT, April 24, 2013. Place: CDC, Building 19, Rooms 245 and 246, 1600 Clifton Road NE., Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 20 people. The public is welcome to participate during the public comment, which is tentatively scheduled from 4:30 to 4:40 p.m. This meeting is also available by teleconference. Please dial (877) 496–4855 and enter code 4363556. Purpose: The Subcommittee will provide advice to the CDC Director through the ACD on strategic and other health disparities and health equity issues and provide guidance on opportunities for CDC. Matters To Be Discussed: The Health Disparities Subcommittee members will discuss CDC’s health equity work in the environmental health and developmental E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 78, Number 55 (Thursday, March 21, 2013)]
[Notices]
[Page 17410]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06436]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Initial review

    The meeting announced below concerns Epi-Centers for the Prevention 
of Healthcare-Associated Infections, Antimicrobial Resistance and 
Adverse Events, Funding Opportunity Announcement (FOA) CK11-
0010301SUPP13, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 1:00 p.m.-4:00 p.m., May 8, 2013 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Epi-Centers for the Prevention of Healthcare-
Associated Infections, Antimicrobial Resistance and Adverse Events, 
FOA CK11-0010301SUPP13''.
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-06436 Filed 3-20-13; 8:45 am]
BILLING CODE 4163-18-P